Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management
HSR may develop during enzyme replacement therapy, which are vital in lysosomal storage diseases, and discontinuation of enzyme replacement therapy is a significant loss for patients with metabolic disorders. These reactions can be treated with premedication and long-term infusions, but some patients may require desensitization protocols for continued treatment.
Authors
- Elif Arık (ORCID: https://orcid.org/0000-0002-7319-8535)
- Ercan Küçükosmanoğlu (ORCID: https://orcid.org/0000-0002-1824-2038)
- Mahmut Cesur (ORCID: https://orcid.org/0000-0001-9260-7587)
- Serpil Albayrak (ORCID: https://orcid.org/0000-0003-3368-6451)
- Murat Karaoğlan (ORCID: https://orcid.org/0000-0002-2861-3568)
- Ahmet Yildirim (ORCID: https://orcid.org/0000-0002-9364-1135)
- Mehmet Keskın (ORCID: https://orcid.org/0000-0002-5544-8991)
- Özlem Keskin (ORCID: https://orcid.org/0000-0002-3061-7832)
- Gaye İnal (ORCID: https://orcid.org/0000-0002-1019-7332)
Institutions
- Gaziantep University (TR)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1515/jpem-2024-0249
- Citations
- 3
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.27